← Back to Search

Cognitive Training for Age-Related Distractibility

N/A
Recruiting
Led By Tae-Ho Lee, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy adult participants
Age range between 18 and 75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up scan before and after attentional practice (2 weeks between scans)
Awards & highlights

Study Summary

This trial looks at how changes in the brain's neural pathways may lead to age-related attentional difficulties and suggests a cognitive training program to improve them.

Who is the study for?
This trial is for healthy adults aged 18-75 who can consent to participate. It's not suitable for those with metal implants, pacemakers, severe claustrophobia, braces, a weight over 250 pounds, pregnancy or severe medical/psychiatric conditions like head trauma.Check my eligibility
What is being tested?
The study tests two tablet-based programs aimed at improving attention in older adults by enhancing brain connectivity. One focuses on multimodal attention practice and the other on criterion task practice to reduce age-related distractibility.See study design
What are the potential side effects?
Since this trial involves cognitive training programs without drugs or invasive procedures, side effects are minimal but may include eye strain or headache from tablet use and potential stress or frustration during challenging tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult.
Select...
I am between 18 and 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~scan before and after attentional practice (2 weeks between scans)
This trial's timeline: 3 weeks for screening, Varies for treatment, and scan before and after attentional practice (2 weeks between scans) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in accuracy on the place-face selective attention task after two weeks
Change in fMRI LC-SN connectivity after two weeks

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Older adult participantsExperimental Treatment2 Interventions
Older adult participants in the study will complete one of two variants of an attention practice program and that will be preceded by, and followed by, an fMRI scan session featuring an attention task
Group II: Younger adult participantsActive Control1 Intervention
Younger adult participants in the study will complete one fMRI scan session featuring an attention task

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor
139 Previous Clinical Trials
27,424 Total Patients Enrolled
Tae-Ho Lee, PhDPrincipal InvestigatorVirginia Polytechnic Institute and State University

Media Library

Aging Clinical Trial 2023: Tablet based adaptive criterion task practice program Highlights & Side Effects. Trial Name: NCT05574634 — N/A
Tablet based adaptive criterion task practice program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05574634 — N/A
Aging Patient Testimony for trial: Trial Name: NCT05574634 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are octogenarians being included in the scope of this clinical exploration?

"For those interested in participating in this trial, the age requirements are between 18 and 75. There are 24 trials for minors under 18 and 763 studies available to senior citizens over 65."

Answered by AI

What criteria must individuals meet to join this experiment?

"This clinical trial seeks 200 adults suffering from alzheimer disease, ranging in age between 18 and 75. In addition to being elderly enough or young enough for the study, participants must be of sound health, consenting willingly to participate, not have had any metal implants during surgery, no fragments within their eyes or a pacemaker on them; those with braces are allowed but should weigh less than 250 pounds. Furthermore they mustn’t either currently pregnant nor likely so in the near future."

Answered by AI

Are there any current openings to join this experiment?

"As indicated on clinicaltrials.gov, patient recruitment for this medical trial is not ongoing. It was initially launched on November 1st 2022 and underwent its last update in October 6th 2022. Although no longer recruiting, there are currently 780 other studies seeking candidates."

Answered by AI

Who else is applying?

What state do they live in?
Texas
Maryland
Colorado
Other
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
0
What site did they apply to?
Virginia Polytechnic Institute and State University

Why did patients apply to this trial?

I feel like I m developing Altheimers. Mild Cognitive impairment with no improvement,.
PatientReceived no prior treatments
To help create better options for everyone aging. I want to help others to find ways to slow the progression and/find a way to totally eliminate Alzheimer’s altogether!
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

When is this starting? mild cognitive impairment will this help?
PatientReceived 2+ prior treatments
~133 spots leftby Jun 2027